Using a ferromagnetic detection system before MRI may boost safety, detecting implanted or embedded items that may contraindicate the exam.
A ferromagnetic detection system may detect implanted or embedded items in patients referred for MRI examinations, according to a study published in the American Journal of Roentgenology.
Magnetic resonance images are becoming more common, particularly as clinicians try to avoid using CT scans to limit radiation exposure to their patients. However, MRI has its own risks because of ferromagnetic implants or foreign bodies that may be exposed to the powerful magnetic fields.
Researchers from University of Southern California and Loyola Marymount University in Los Angeles investigated the feasibility of using a ferromagnetic detection device to screen patients for implants and foreign objects before undergoing MRI.
Volunteers were recruited for screening with a “pillar-type” ferromagnetic detection device. Sixty-seven different implants and other objects were chosen for testing (43 pulse generators, five electronic devices, six stents, three CSF shut-off valves, three orthopedic implants, four bullets, and three “other). The volunteers were first screened without any ferromagnetic objects on their body. After confirmation of the system’s function, objects were attached to the volunteers’ body in a realistic in situ location.
The tests found 58 true-positive, four true-negative, no false-positive, and five false-negative findings for a sensitivity of 92 percent and specificity of 100 percent.
The researchers concluded that this type of screening may be used not only for detection of external ferromagnetic objects, but also for implanted or embedded items. They suggest further research to determine the system’s use in the clinical setting.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.